Intelligent Bio Solutions is a medical technology company focused on developing and delivering testing and screening solutions. Co.'s product portfolio includes: Intelligent Fingerprinting Platform, which consists of Intelligent Fingerprinting Drug Screening System, a sweat-based fingerprint diagnostic testing products designed to detect drugs of abuse including opioids, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine; and Biosensor Platform, which consists of Saliva Glucose Biosensor, designed to detect multiple biological analytes by substituting the Glucose Oxidase enzyme with an alternative for each analyte. The INBS average annual return since 2020 is shown above.
The Average Annual Return on the INBS average annual return since 2020 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether INBS average annual return since 2020 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the INBS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|